BioCentury | Jan 1, 2021
Product Development

Not done yet. The COVID R&D Alliance has plenty on its plate for 2021

...mAb against plasma kallikrein, and zilucoplan from UCB Pharma S.A....
BioCentury | Sep 19, 2019
Product Development

Industry seeks ICH revisions to curb influx of irrelevant pharmacovigilance data

...hitting industry and regulators,” said Peter Verdru, former head of patient safety at UCB Group’s UCB Pharma S.A....
BioCentury | Oct 21, 2013
Product Development

TransCelerate up to speed

...adding more members and that the board approved the latest member - UCB Group 's UCB Pharma S.A....
BioCentury | Jun 13, 2011
Company News

DiaGenic management update

...created position, effective Sept. 1, formerly VP of global exploratory development at UCB Group 's UCB Pharma S.A....
BioCentury | Jan 11, 2010
Company News

Clavis management update

...Olav Hellebo as CEO, effective Feb. 1, formerly president of immunology operations and SVP at UCB Pharma S.A....
BioCentury | Jan 9, 2010
Company News

Clavis names Hellebo CEO

...as CEO, effective Feb. 1. Hellebo was previously president of immunology operations and SVP at UCB Pharma S.A....
BioCentury | Jan 28, 2008
Company News

Entelos Inc., UCB deal

...UCB's UCB Pharma S.A. subsidiary and Entelos will use Entelos' PhysioLab platform to conduct research with an in...
Items per page:
1 - 7 of 7
BioCentury | Jan 1, 2021
Product Development

Not done yet. The COVID R&D Alliance has plenty on its plate for 2021

...mAb against plasma kallikrein, and zilucoplan from UCB Pharma S.A....
BioCentury | Sep 19, 2019
Product Development

Industry seeks ICH revisions to curb influx of irrelevant pharmacovigilance data

...hitting industry and regulators,” said Peter Verdru, former head of patient safety at UCB Group’s UCB Pharma S.A....
BioCentury | Oct 21, 2013
Product Development

TransCelerate up to speed

...adding more members and that the board approved the latest member - UCB Group 's UCB Pharma S.A....
BioCentury | Jun 13, 2011
Company News

DiaGenic management update

...created position, effective Sept. 1, formerly VP of global exploratory development at UCB Group 's UCB Pharma S.A....
BioCentury | Jan 11, 2010
Company News

Clavis management update

...Olav Hellebo as CEO, effective Feb. 1, formerly president of immunology operations and SVP at UCB Pharma S.A....
BioCentury | Jan 9, 2010
Company News

Clavis names Hellebo CEO

...as CEO, effective Feb. 1. Hellebo was previously president of immunology operations and SVP at UCB Pharma S.A....
BioCentury | Jan 28, 2008
Company News

Entelos Inc., UCB deal

...UCB's UCB Pharma S.A. subsidiary and Entelos will use Entelos' PhysioLab platform to conduct research with an in...
Items per page:
1 - 7 of 7